228 related articles for article (PubMed ID: 25220188)
1. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.
Coppola D; Balducci L; Chen DT; Loboda A; Nebozhyn M; Staller A; Fulp WJ; Dalton W; Yeatman T; Brem S
J Geriatr Oncol; 2014 Oct; 5(4):389-99. PubMed ID: 25220188
[TBL] [Abstract][Full Text] [Related]
2. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.
Zhang J; Wang P; Ji W; Ding Y; Lu X
Int J Neurosci; 2017 Mar; 127(3):210-217. PubMed ID: 27050560
[TBL] [Abstract][Full Text] [Related]
5. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
6. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Wang H; Jiang C
Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of gliomas strongly predicts survival.
Freije WA; Castro-Vargas FE; Fang Z; Horvath S; Cloughesy T; Liau LM; Mischel PS; Nelson SF
Cancer Res; 2004 Sep; 64(18):6503-10. PubMed ID: 15374961
[TBL] [Abstract][Full Text] [Related]
9. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
10. Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.
Brown CE; Warden CD; Starr R; Deng X; Badie B; Yuan YC; Forman SJ; Barish ME
PLoS One; 2013; 8(10):e77769. PubMed ID: 24204956
[TBL] [Abstract][Full Text] [Related]
11. A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
Luo H; Tao C; Long X; Huang K; Zhu X
Aging (Albany NY); 2021 Jun; 13(12):16198-16218. PubMed ID: 34114970
[TBL] [Abstract][Full Text] [Related]
12. Aging-related genes are potential prognostic biomarkers for patients with gliomas.
Xiao G; Zhang X; Zhang X; Chen Y; Xia Z; Cao H; Huang J; Cheng Q
Aging (Albany NY); 2021 May; 13(9):13239-13263. PubMed ID: 33946049
[TBL] [Abstract][Full Text] [Related]
13. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
Lu G; Chang JT; Liu Z; Chen Y; Li M; Zhu JJ
Mol Neurobiol; 2016 Nov; 53(9):6511-6525. PubMed ID: 26614510
[TBL] [Abstract][Full Text] [Related]
16. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
[TBL] [Abstract][Full Text] [Related]
18. Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas.
Cheng YS; Lin C; Cheng YP; Yu YL; Tang CT; Hueng DY
Neurol India; 2014; 62(4):406-9. PubMed ID: 25237947
[TBL] [Abstract][Full Text] [Related]
19. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
20. [Occurrence and molecular pathology of high grade gliomas].
Murnyák B; Csonka T; Hegyi K; Méhes G; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):312-21. PubMed ID: 24358686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]